Permeabilized cardiac myocyte preparations
| Cardiac myocyte preparations | Length (µm) | Width (µm) | SL (µm) | Passive tension (kN·m−2) | Maximum force (µN) | Maximum tension (kN·m−2) | Maximal ktr (s−1) | pCa for half-max. tension | Relative tension half-max. pCa | |
|---|---|---|---|---|---|---|---|---|---|---|
| Rat (N = 5) | n = 5 | 144 ± 10 | 26 ± 3 | 2.23 ± 0.01 | 1.2 ± 0.3 | 17.2 ± 3.0 | 50 ± 10 | 9.83 ± 0.42 | 5.90 ± 0.06 | 0.44 ± 0.02 |
| cMyBP-C WT (N = 5) + MAVA | n = 5 | 117 ± 9 | 30 ± 3 | 2.27 ± 0.04 | 1.0 ± 0.2 | 16.6 ± 4.1 10.7 ± 2.9* | 33 ± 3 20 ± 2** | 12.30 ± 2.10 9.01 ± 1.57* | 5.94 ± 0.02 5.74 ± 0.02** | 0.45 ± 0.05 0.50 ± 0.02 |
| cMyBP-C KO (N = 5) + MAVA | n = 5 | 120 ± 14 | 27 ± 2 | 2.23 ± 0.01 | 1.3 ± 0.2 | 16.7 ± 2.2 10.6 ± 1.5** | 45 ± 7 29 ± 6** | 14.25 ± 2.17 8.77 ± 1.28* | 5.88 ± 0.02 5.68 ± 0.05** | 0.39 ± 0.02 0.55 ± 0.02*** |
| Cardiac myocyte preparations | Length (µm) | Width (µm) | SL (µm) | Passive tension (kN·m−2) | Maximum force (µN) | Maximum tension (kN·m−2) | Maximal | pCa for half-max. tension | Relative tension half-max. pCa | |
|---|---|---|---|---|---|---|---|---|---|---|
| Rat ( | 144 ± 10 | 26 ± 3 | 2.23 ± 0.01 | 1.2 ± 0.3 | 17.2 ± 3.0 | 50 ± 10 | 9.83 ± 0.42 | 5.90 ± 0.06 | 0.44 ± 0.02 | |
| cMyBP-C WT ( | 117 ± 9 | 30 ± 3 | 2.27 ± 0.04 | 1.0 ± 0.2 | 16.6 ± 4.1 | 33 ± 3 | 12.30 ± 2.10 | 5.94 ± 0.02 | 0.45 ± 0.05 | |
| cMyBP-C KO ( | 120 ± 14 | 27 ± 2 | 2.23 ± 0.01 | 1.3 ± 0.2 | 16.7 ± 2.2 10.6 ± 1.5** | 45 ± 7 29 ± 6** | 14.25 ± 2.17 8.77 ± 1.28* | 5.88 ± 0.02 5.68 ± 0.05** | 0.39 ± 0.02 0.55 ± 0.02*** |
Values are means ± SEM; *P < 0.05, ***P < 0.01 ***P < 0.001 cMyBP-C before mavacamten (MAVA) versus with MAVA via paired t test.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.